Showing results (1-10 of 205) with videos related to
Sort By:
Pageof 21
Vascular Health and Risk Management|September 16, 2021
Elevated Lipoprotein(a): Background, Current Insights and Future Potential TherapiesAhmed Handhle, Adie Viljoen, Anthony S WierzbickiCurrent Opinion in Cardiology|May 27, 2020
Low cholesterol syndrome and drug developmentAhmed Handhle, Adie Viljoen, Radha Ramachandran, et al.Current Drug Targets|April 10, 2009
Potential options to treat hypertriglyceridaemiaAdie Viljoen, Anthony S WierzbickiDrug, Healthcare and Patient Safety|June 25, 2011
Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemiaAdie Viljoen, Anthony S WierzbickiExpert Opinion on Medical Diagnostics|March 19, 2013
Towards companion diagnostics for the management of statin therapyAdie Viljoen, Anthony S WierzbickiExpert Opinion on Biological Therapy|June 2, 2016
Anti-sense oligonucleotide therapies for the treatment of hyperlipidaemiaAnthony S Wierzbicki, Adie ViljoenDrug Safety|January 20, 2010
Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practiceAnthony S Wierzbicki, Adie ViljoenExpert Review of Endocrinology & Metabolism|February 21, 2019
Colesevelam: an improved bile acid sequestrant for treating hypercholesterolemia and improving diabetesAdie Viljoen, Anthony S WierzbickiExpert Review of Cardiovascular Therapy|March 31, 2012
Diagnosis and treatment of severe hypertriglyceridemiaAdie Viljoen, Anthony S WierzbickiExpert Opinion on Biological Therapy|November 7, 2012
Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiencyAnthony S Wierzbicki, Adie ViljoenPageof 21